George J D, Manson J M
Cancer Res. 1986 Nov;46(11):5671-5.
C57BL/6J (B6) and DBA/2J (D2) mice have different susceptibilities to developmental toxicity and transplacental carcinogenesis induced by in utero exposure to polycyclic aromatic hydrocarbons, which has been associated with polycyclic aromatic hydrocarbon metabolism and inducibility at the Ah locus. The distribution of total 3-methylcholanthrene (3-MC)-associated radioactivity in maternal, placental, and fetal tissues of beta-naphthoflavone-pretreated pregnant B6 and D2 mice was determined up to 12 h after p.o. exposure to [6-14C]-3-MC (63 mg/kg, 20 mu Ci) on gestational day 17. 3-MC-associated radioactivity in maternal plasma was not significantly different in the two strains. However, D2 tissue homogenates had consistently higher levels of 3-MC-associated radioactivity, which included both bound and free parent compound and metabolites. Increased metabolism of 3-MC by B6 maternal liver was suggested by the induced levels of aryl hydrocarbon hydroxylase activity in that tissue and by the observation that levels of total radioactivity decreased more rapidly in B6 tissues than in D2 tissues. The D2 fetal lung, the target tissue for 3-MC-induced transplacental carcinogenesis, appeared to accumulate 3-MC-associated radioactivity for a longer period of time than either the D2 fetal liver or the B6 fetal tissues. This study suggests that the genetic differences in fetal susceptibility to the developmental toxicity and transplacental carcinogenesis of 3-MC may be related to the presystemic elimination of the compound from both maternal and fetal tissues.
C57BL/6J(B6)小鼠和DBA/2J(D2)小鼠对子宫内暴露于多环芳烃所诱导的发育毒性和经胎盘致癌作用具有不同的易感性,这与多环芳烃代谢及Ah位点的诱导性有关。在妊娠第17天经口给予[6-¹⁴C]-3-甲基胆蒽(63 mg/kg,20 μCi)后,测定了β-萘黄酮预处理的妊娠B6和D2小鼠母体、胎盘和胎儿组织中总3-甲基胆蒽(3-MC)相关放射性的分布,直至12小时。两品系母体血浆中3-MC相关放射性无显著差异。然而,D2组织匀浆中3-MC相关放射性水平始终较高,其中包括结合态和游离态的母体化合物及其代谢产物。B6母体肝脏中3-MC代谢增加,这可由该组织中芳烃羟化酶活性的诱导水平以及B6组织中总放射性水平比D2组织下降更快的观察结果表明。3-MC诱导的经胎盘致癌作用的靶组织D2胎儿肺,似乎比D2胎儿肝脏或B6胎儿组织积累3-MC相关放射性的时间更长。本研究表明,胎儿对3-MC发育毒性和经胎盘致癌作用易感性的遗传差异可能与该化合物在母体和胎儿组织中的首过消除有关。